Acute Innovations

What Acute Innovations does

Acute Innovations, founded in 2006 and based in Hillsboro, United States, is a medical device company focused on developing solutions for challenging thoracic procedures, with a particular concentration in chest wall and sternal closure systems. The company is identified as a major participant in the global sternal closure systems market, competing alongside larger orthopedic and medical device players including Zimmer Biomet Holdings, KLS Martin Group, and Stryker. Its product portfolio — operating in conjunction with Acumed LLC's chest wall line — includes the RibLoc U Plus Chest Wall Plating System, AcuTie II sternal closure device, and BioBridge biologic adjunct. These products address thoracic surgeons' needs in sternal closure and chest wall reconstruction procedures.

The company's go-to-market operates within Acumed LLC's broader orthopedic and craniomaxillofacial infrastructure, with Acumed being a Marmon Medical / Berkshire Hathaway company and OsteoMed a wholly-owned subsidiary. Distribution relies on a rep-finding model typical of specialty medical devices, with contact channels (phone 888.627.9957 and [email protected]) and surgeon education via mobile cadaver labs and procedure-focused events. Leadership includes a Director of Global Sales & Marketing (Will Crawford) and an Operations Manager (Tori Terjeson), supporting both domestic and international commercial activity.

Revenue mechanics, pricing, customer segmentation, and headcount are not disclosed in the source material, limiting visibility into the company's financial profile. The addressable sternal closure systems market is projected to expand from USD 2,295.25 million in 2022 to USD 3,446.26 million by 2031 at a 5.3% CAGR, providing a stable but moderately growing demand backdrop. No AI, software, or digital platform capabilities specific to Acute Innovations are documented in the inputs.

Name

Acute Innovations

Legal name

Acute Innovations

Website

https://acuteinnovations.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Acute Innovations is a medical device company developing solutions for challenging thoracic procedures, with a portfolio of chest wall plating and sternal closure systems including RibLoc U Plus, AcuTie II, and BioBridge, operating within Acumed LLC's orthopedic infrastructure.

Ownership category

akta.pro rank

Product category

Sternal Closure and Chest Wall Implants

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)

akta.pro secondary industry

Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts) (HLAHAFAH)

Keywords

• Sternal closure systems
• Chest wall plating
• Rib fracture fixation
• Thoracic surgical devices
• Orthopedic implants

Headquarters

HQ city

Hillsboro

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Marketing or Sales, Supply Chain, Technology or R&D, Operations, Infrastructure

Core offering

Acute Innovations develops and manufactures surgical implants and plating systems used in chest wall and sternal closure procedures. Its product portfolio includes the RibLoc U Plus Chest Wall Plating System, the AcuTie II sternal closure system, and the BioBridge resorbable implant, designed for thoracic surgeons performing rib fracture fixation, sternal closure, and related reconstructive procedures.

Product overview

Acute Innovations is a major company in the global sternal closure systems market, competing alongside Zimmer Biomet Holdings, KLS Martin Group, and Stryker. The company operates in a market projected to grow from USD 2,295.25 million in 2022 to USD 3,446.26 million by 2031.

Differentiator

Problem solved

Functional benefit

Products and services

• RibLoc U Plus Chest Wall Plating System A plating system used by surgeons for the stabilization and fixation of rib fractures and chest wall reconstruction.
• AcuTie II A sternal closure device used by surgeons to rejoin the sternum following cardiothoracic procedures.
• BioBridge A resorbable implant used in chest wall repair and reconstruction procedures.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves3 records

Expansion highlights2 records

Broad incumbents

• Medtronic: Large medtech incumbent with cardiac surgery and surgical fixation products reaching the same cardiac surgery departments that purchase sternal closure hardware.
• Smith+Nephew: Global orthopedic and surgical devices company whose trauma and extremities portfolio competes for the hospital fixation accounts that Acute Innovations serves.
• DePuy Synthes (Johnson & Johnson MedTech): Broad orthopedic trauma and surgical fixation incumbent with plates and screws relevant to sternal and chest wall repair, competing for the same hospital and surgeon relationships as Acute Innovations.
• B. Braun Melsungen: Diversified medical device manufacturer with surgical instruments, sutures, and sternal closure systems serving cardiac surgery customers, overlapping with Acute Innovations' thoracic customer base.

Emerging players

• CONMED: Medical device company focused on surgical and orthopedic products including fixation hardware, with overlapping customer relationships in the hospitals where sternal closure devices are sold.
• Integra LifeSciences: Specialty surgical and orthopedic company with a smaller-scale but adjacent fixation portfolio targeting similar thoracic and orthopedic surgery niches as Acute Innovations.

Direct peers

• KLS Martin Group: Named alongside Acute Innovations as a major player in the global sternal closure systems market. KLS Martin specializes in surgical instruments and sternal closure products, making it one of the closest direct peers.
• Zimmer Biomet Holdings: Explicitly named as a major competitor to Acute Innovations in the global sternal closure systems market. Zimmer Biomet offers sternal closure hardware alongside broad orthopedic and surgical portfolios, competing directly for thoracic surgery accounts.
• Stryker: Identified as a major competitor in the sternal closure systems market. Stryker's orthopedics and surgical products include fixation hardware and chest wall solutions aimed at the same cardiac and thoracic surgery customers.
• Acumed: Acumed surfaces the Chest Wall product family (RibLoc U Plus, AcuTie II, BioBridge) used by Acute Innovations. As the brand under which Acute Innovations' thoracic products are commercialized, Acumed is the closest channel and product analogue.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Acute Innovations